NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
14.16
+0.17 (1.22%)
Aug 25, 2026, 4:00 PM EDT - Market closed
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $486.03 million as of August 26, 2026. Its market cap has increased by 63.43% in one year.
Market Cap
486.03M
Enterprise Value
504.26M
1-Year Change
63.43%
Ranking
Category
Stock Price
$14.16
ChartMarket Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $486.03M, an increase of 23.58%. That is a compound annual growth rate of 4.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 486.03M | -5.49% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Delcath Systems | 581.20M |
| Cytek Biosciences | 577.13M |
| BrainsWay | 572.43M |
| Cerus | 542.10M |
| Tactile Systems Technology | 529.16M |
| Senseonics Holdings | 495.96M |
| ClearPoint Neuro | 462.75M |
| Sight Sciences | 461.64M |